{"@attributes":{"version":"2.0"},"channel":{"title":"Blog","link":"https:\/\/blog.mediately.co\/de","description":"Discover the latest trends in the pharmaceutical industry, gain insights into doctors' behavior, and explore effective digital advertising solutions.","language":"de","pubDate":"Thu, 08 Jan 2026 07:25:19 GMT","item":[{"title":"Advancing early breast cancer treatment through precision oncology","link":"https:\/\/blog.mediately.co\/de\/dejan-juric-interview","description":"
\n \"Advancing <\/a> \n<\/div> \n

We had the opportunity to speak with Assist. Prof. Dejan Juric, a Croatian-American clinical investigator, Harvard professor of oncology, and medical oncology specialist at Massachusetts General Hospital<\/span>, to discuss current developments and future directions in early breast cancer care.<\/span> <\/p>","category":"Interview","pubDate":"Mon, 03 Nov 2025 13:53:33 GMT","guid":"https:\/\/blog.mediately.co\/de\/dejan-juric-interview"},{"title":"How to target healthcare professionals?","link":"https:\/\/blog.mediately.co\/de\/how-to-target-healthcare-professionals","description":"

\n \"targeting-healthcare-professionals\" <\/a> \n<\/div> \n

Healthcare professionals (HCPs) are a unique audience when it comes to marketing. They have busy schedules and make critical decisions that impact the health and wellbeing of their patients on a daily basis. Not only do they regularly attend trainings and educational events in their field, but they also proactively seek out new information and research to improve their practice. Marketers who can deliver clear, concise messaging that quickly communicates the value proposition of their product or service will be much more likely to cut through the noise and get noticed. In this blog post, we focus on targeting and segmentation of the audience in order to reach the audience faster and more effectively and answer a question on how to target healthcare professionals. 
<\/em><\/p>","category":["Digital marketing","Healthcare marketing"],"pubDate":"Wed, 09 Jul 2025 12:48:44 GMT","guid":"https:\/\/blog.mediately.co\/de\/how-to-target-healthcare-professionals"},{"title":"The future of diabetes: Prevention, personalization, and progress","link":"https:\/\/blog.mediately.co\/de\/the-future-of-diabetes-prevention-personalization-and-progress","description":"

\n \"cover-image\" <\/a> \n<\/div> \n

Professor Stefano del Prato<\/span>, a globally recognized diabetologist and researcher, recently shared his invaluable insights on the evolving landscape of type 2 diabetes care. With decades of experience in diabetes research and clinical practice, professor Stefano del Prato highlighted the transformative advancements in treatment, the critical role of prevention, and the promising future of personalized medicine. His reflections underscore the importance of innovation<\/span>, collaboration<\/span>, and patient-centered approaches<\/span> in addressing the challenges of diabetes care.<\/span><\/p>","category":"Interview","pubDate":"Wed, 09 Jul 2025 12:47:29 GMT","guid":"https:\/\/blog.mediately.co\/de\/the-future-of-diabetes-prevention-personalization-and-progress"},{"title":"How digitalization is shaping healthcare: Insights from a leading Czech oncologist","link":"https:\/\/blog.mediately.co\/de\/how-digitalization-is-shaping-healthcare-insights-from-a-leading-czech-oncologist","description":"

\n \"cover-image\" <\/a> \n<\/div> \n

Dr. Petr\u00e1kov\u00e1 is a distinguished authority in Czech oncology. She has been working at the Masaryk Memorial Cancer Institute (MO\u00da) in Brno since 1993, where she is also a Head Physician at the Clinic of Comprehensive Cancer Care. She is the founder of St. Elizabeth Hospice, an accomplished author and reviewer of scientific articles and publications, as well as a passionate lecturer and mentor. She also has a long-standing commitment to the specialised team, focusing on breast cancer treatment.

As a member of the Czech Society for Oncology (\u010cLS JEP) and the European Society for Medical Oncology, Dr. Petr\u00e1kov\u00e1 contributes significantly to the advancement of oncology on both national and European levels.<\/p> \n

 <\/p>","category":"Interview","pubDate":"Wed, 09 Jul 2025 12:46:22 GMT","guid":"https:\/\/blog.mediately.co\/de\/how-digitalization-is-shaping-healthcare-insights-from-a-leading-czech-oncologist"},{"title":"Drug ads format: Creating clickable banner ads to increase sales","link":"https:\/\/blog.mediately.co\/de\/drug-ads-format","description":"

\n \"banner-post\" <\/a> \n<\/div> \n

In today's world of drug ads formats, a well-made banner can effectively communicate your brand's message, attract viewers and ultimately increase sales. In this blog post, we will explore the key elements of creating a successful banner and explain the basics of banner advertising.<\/p>","category":["Digital marketing","Healthcare marketing"],"pubDate":"Wed, 09 Jul 2025 12:45:24 GMT","guid":"https:\/\/blog.mediately.co\/de\/drug-ads-format"},{"title":"Today we have superior possibilities in the treatment of CLL","link":"https:\/\/blog.mediately.co\/de\/dino-dujmovic-interview","description":"

\n \"Dino-interview\" <\/a> \n<\/div> \n

Dr. sc. Dino Dujmovi\u0107, a hematologist from the University Hospital Centre (KBC) Zagreb, is a clinician who speaks passionately about his work and specialty. We talked about important topics - treatment options for hematological diseases in Croatia, and especially about his specialty - lymphoproliferative diseases and opportunities for patients and the future of hematology. We also touched on other topics, such as the new digital tools for hematologists in the Mediately application, which provide assistance in clinical practice, in the development of which he himself participated. <\/p>","category":"Interview","pubDate":"Wed, 09 Jul 2025 12:44:14 GMT","guid":"https:\/\/blog.mediately.co\/de\/dino-dujmovic-interview"},{"title":"Omnichannel pharma marketing: Driving success in the digital era","link":"https:\/\/blog.mediately.co\/de\/omnichannel-pharma","description":"

\n \"omnichannel-pharma\" <\/a> \n<\/div> \n

The pharmaceutical industry is always changing and expanding, as there are new products, technologies and customer demands to keep up with. This makes marketing as an industry more complicated because companies need to reach customers through a variety of different channels and touchpoints.

Omnichannel marketing is a strategy that addresses this complexity. It aims to connect with customers through all channels and touchpoints. In this blog post, you will find out about the advantages of omnichannel marketing in the pharmaceutical industry and its key elements. <\/p>","category":["Digital marketing","Healthcare marketing"],"pubDate":"Wed, 09 Jul 2025 12:42:54 GMT","guid":"https:\/\/blog.mediately.co\/de\/omnichannel-pharma"},{"title":"The ultimate guide to understanding the buyer's journey in healthcare marketing","link":"https:\/\/blog.mediately.co\/de\/the-ultimate-guide-to-understanding-the-buyers-journey-in-healthcare-marketing","description":"

\n \"buyer's-journey\" <\/a> \n<\/div>","category":"Digital marketing","pubDate":"Wed, 09 Jul 2025 12:41:37 GMT","guid":"https:\/\/blog.mediately.co\/de\/the-ultimate-guide-to-understanding-the-buyers-journey-in-healthcare-marketing"},{"title":"We have to pursue the best glucose control possible","link":"https:\/\/blog.mediately.co\/de\/francesco-giorgino-interview","description":"
\n \"FG-interview\" <\/a> \n<\/div> \n

It has been a while since Prof. Dr. Francesco Giorgino, currently vice-president of EASD and professor of endocrinology and metabolism, Head of the Division of Endocrinology at the University Hospital Policlinico Consorziale, University of Bari Aldo Moro in Italy talked with us about new trends in the management of diabetes. His words are still more than worth remembering. <\/p>","category":"Interview","pubDate":"Wed, 09 Jul 2025 12:40:32 GMT","guid":"https:\/\/blog.mediately.co\/de\/francesco-giorgino-interview"},{"title":"Dermatology drug search trends, with a focus on atopic dermatitis & plaque psoriasis treatments","link":"https:\/\/blog.mediately.co\/de\/dermatology-drug-search-trends","description":"

\n \"dermatology-drug-search\" <\/a> \n<\/div> \n

In dermatology, few conditions carry as much significance and impact as atopic dermatitis and plaque psoriasis. These two chronic skin disorders share the commonality of affecting millions of individuals worldwide, profoundly influencing their quality of life and necessitating ongoing management and treatment.

Overall, the treatment landscape for atopic dermatitis and plaque psoriasis is evolving quickly, with advancements in biologic therapies, Janus kinase (JAK) inhibitors, personalized medicine, and topical treatments. Pharmaceutical companies face increasing competition as they strive to develop innovative therapies that address the unmet needs of patients with these chronic skin disorders.<\/p>","category":["Healthcare trends","Research"],"pubDate":"Wed, 09 Jul 2025 12:39:05 GMT","guid":"https:\/\/blog.mediately.co\/de\/dermatology-drug-search-trends"}]}}